Conti C R, Feldman R L, Pepine C J, Hill J A, Conti J B
Am J Med. 1983 Jun 27;74(6B):28-32. doi: 10.1016/0002-9343(83)90851-3.
The effects of sublingual and intracoronary nitrates on coronary artery diameter were evaluated in five separate experiments in man. The first three are concerned with sublingual nitrates and the last two with intracoronary nitrates. The data obtained indicate that (1) administration of a fixed dose sublingual nitrate results in an increase in percent coronary artery stenosis compared with control measurements; (2) small doses of sublingual nitrates can dilate coronary arteries without a significant reduction in systemic arterial pressure or increase in heart rate; (3) the magnitude of percent coronary artery dilation after a fixed dose of sublingual nitrate is inversely related to the size of the coronary artery, that is, the smaller the coronary artery diameter the greater the relative dilation after administration of sublingual nitrate; (4) fixed dose sublingual nitrate often dilated coronary stenoses, but the more narrow stenoses were less likely to dilate; (5) the optimal dose of intracoronary nitrate required to produce maximal or near maximal coronary dilation without clinically important systemic hemodynamic effects is in the range of 200 micrograms; (6) intracoronary nitrate is a more potent coronary artery dilator than sublingual nifedipine, when administered as a 10 mg dose.
在五项针对人体的独立实验中,评估了舌下含服和冠状动脉内注射硝酸盐对冠状动脉直径的影响。前三项实验涉及舌下含服硝酸盐,后两项涉及冠状动脉内注射硝酸盐。获得的数据表明:(1)与对照测量相比,给予固定剂量的舌下含服硝酸盐会导致冠状动脉狭窄百分比增加;(2)小剂量的舌下含服硝酸盐可扩张冠状动脉,而不会使体动脉压显著降低或心率增加;(3)给予固定剂量的舌下含服硝酸盐后,冠状动脉扩张百分比的幅度与冠状动脉大小呈负相关,即冠状动脉直径越小,舌下含服硝酸盐后相对扩张越大;(4)固定剂量的舌下含服硝酸盐常可扩张冠状动脉狭窄,但狭窄越严重,扩张的可能性越小;(5)在不产生具有临床意义的体循环血流动力学影响的情况下,产生最大或接近最大冠状动脉扩张所需的冠状动脉内注射硝酸盐的最佳剂量在200微克范围内;(6)当以10毫克剂量给药时,冠状动脉内注射硝酸盐比舌下含服硝苯地平是更有效的冠状动脉扩张剂。